FABP4 and androgen insensitivity syndrome: Although various biomarkers for the management of patients with AIS (such as endostatin, sphingosine 1-phosphate, and fatty acid-binding protein 4) have been noticed in some studies, most of them are detected at a single point and multipoint detection study in the long term is rare (42–44).